By Show-Me State Times |
Nov 12, 2024
Concerns are growing about the federal 340B drug pricing program, originally designed to make medications affordable for low-income patients, as evidence suggests some large health systems are using it to generate profits. The 340B program, aimed at providing safety-net hospitals with significantly discounted drugs, has grown into the second-largest federal prescription drug initiative, surpassing Medicare Parts B and D.